Emergence of antibiotic-resistant pneumococcal serotypes causing invasive pneumococcal disease in children, Spain
View abstract on PubMed
Summary
This summary is machine-generated.Pneumococcal conjugate vaccines (PCVs) reduced invasive pneumococcal disease (IPD) in children. However, antibiotic-resistant strains, particularly non-PCV13 serotypes like 24F, are increasing, posing a new challenge.
Area Of Science
- Microbiology
- Epidemiology
- Vaccinology
Background
- Pneumococcal conjugate vaccines (PCVs) have decreased invasive pneumococcal disease (IPD) globally.
- The emergence of non-vaccine serotypes with reduced antibiotic susceptibility is a concern.
- Surveillance of antibiotic resistance patterns is crucial for public health.
Purpose Of The Study
- To analyze changes in antibiotic-resistant *Streptococcus pneumoniae* strains causing IPD in children.
- To evaluate the impact of PCV13 and the COVID-19 pandemic on antibiotic resistance.
- To identify prevalent non-vaccine serotypes contributing to IPD-RS.
Main Methods
- National surveillance of 4,455 pediatric IPD isolates in Spain (2009-2023).
- Analysis of antibiotic susceptibility to penicillin and erythromycin.
- Stratification of data into six periods: pre-PCV13, early, middle, late PCV13, COVID-19, and reopening.
Main Results
- Overall IPD cases decreased significantly (over 60% in 1-4 years, 50% in <1 year).
- Increased incidence of IPD-RS caused by non-PCV13 serotypes, with 24F being most prevalent.
- PCV13 introduction substantially reduced IPD; COVID-19 caused a temporary decline in resistant strains.
Conclusions
- PCV13 effectively reduced IPD but led to an increase in non-PCV13 serotype resistance.
- Serotype 24F is a growing concern for antibiotic resistance in IPD.
- Pandemic measures temporarily lowered resistant strain burden, followed by recovery.
Related Concept Videos
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
The pathophysiology of pneumonia involves the following steps:
• Inhalation of Infectious Agents: Pneumonia typically begins when pathogenic organisms (bacteria, viruses, fungi) are inhaled or aspirated into the lower respiratory tract.
• Overcoming Lung Defenses: Ideally, the respiratory tract has defense mechanisms like mucociliary clearance and cough reflex to prevent the establishment of pathogenic organisms. If these defenses are compromised, or the pathogen is highly...
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
• For...

